1. Effect of enzalutamide on health-related quality of life, pain, and skeletal-related events in asymptomatic and minimally symptomatic, chemotherapy-naive patients with metastatic castration-resistant prostate cancer (PREVAIL): results from a randomised, phase 3 trial. Issue 5 (May 2015) Authors: Loriot, Yohann; Miller, Kurt; Sternberg, Cora N; Fizazi, Karim; De Bono, Johann S; Chowdhury, Simon; Higano, Celestia S; Noonberg, Sarah; Holmstrom, Stefan; Mansbach, Harry; Perabo, Frank G; Phung, De; Ivanescu, Cristina; Skaltsa, Konstantina; Beer, Tomasz M; Tombal, Bertrand Journal: Lancet oncology Issue: Volume 16:Issue 5(2015:May) Page Start: 509 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer. (October 2022) Authors: Oaknin, Ana; Monk, Bradley J.; Vergote, Ignace; Cristina de Melo, Andreia; Kim, Yong-Man; Lisyanskaya, Alla S.; Samouëlian, Vanessa; Kim, Hee Seung; Gotovkin, Evgeniy A.; Damian, Fernanda; Chang, Chih-Long; Takahashi, Shunji; Li, Jingjin; Mathias, Melissa; Fury, Matthew G.; Ivanescu, Cristina; Re... Journal: European journal of cancer Issue: Volume 174(2022) Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Patient-reported outcomes following enzalutamide or placebo in men with non-metastatic, castration-resistant prostate cancer (PROSPER): a multicentre, randomised, double-blind, phase 3 trial. Issue 4 (April 2019) Authors: Tombal, Bertrand; Saad, Fred; Penson, David; Hussain, Maha; Sternberg, Cora N; Morlock, Robert; Ramaswamy, Krishnan; Ivanescu, Cristina; Attard, Gerhardt Journal: Lancet oncology Issue: Volume 20:Issue 4(2019) Page Start: 556 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial. Issue 2 (February 2019) Authors: Cella, David; Grünwald, Viktor; Escudier, Bernard; Hammers, Hans J; George, Saby; Nathan, Paul; Grimm, Marc-Oliver; Rini, Brian I; Doan, Justin; Ivanescu, Cristina; Paty, Jean; Mekan, Sabeen; Motzer, Robert J Journal: Lancet oncology Issue: Volume 20:Issue 2(2019) Page Start: 297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trial. Issue 2 (February 2022) Authors: Cella, David; Motzer, Robert J; Suarez, Cristina; Blum, Steven I; Ejzykowicz, Flavia; Hamilton, Melissa; Wallace, Joel F; Simsek, Burcin; Zhang, Joshua; Ivanescu, Cristina; Apolo, Andrea B; Choueiri, Toni K Journal: Lancet oncology Issue: Volume 23:Issue 2(2022) Page Start: 292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Patient‐reported outcomes with cemiplimab monotherapy for first‐line treatment of advanced non–small cell lung cancer with PD‐L1 of ≥50%: The EMPOWER‐Lung 1 study. Issue 1 (29th October 2022) Authors: Gümüş, Mahmut; Chen, Chieh‐I; Ivanescu, Cristina; Kilickap, Saadettin; Bondarenko, Igor; Özgüroğlu, Mustafa; Gogishvili, Miranda; Turk, Haci M.; Cicin, Irfan; Harnett, James; Mastey, Vera; Naumann, Ulrike; Reaney, Matthew; Konidaris, Gerasimos; Sasane, Medha; Brady, Keri J. S.; Li, Siyu; Gullo, G... Journal: Cancer Issue: Volume 129:Issue 1(2023) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The association between health-related quality-of-life scores and clinical outcomes in metastatic castration-resistant prostate cancer patients: Exploratory analyses of AFFIRM and PREVAIL studies. (December 2017) Authors: Beer, Tomasz M.; Miller, Kurt; Tombal, Bertrand; Cella, David; Phung, De; Holmstrom, Stefan; Ivanescu, Cristina; Skaltsa, Konstantina; Naidoo, Shevani Journal: European journal of cancer Issue: Volume 87(2017) Page Start: 21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The impact of enzalutamide on quality of life in men with metastatic hormone‐sensitive prostate cancer based on prior therapy, risk, and symptom subgroups. Issue 13 (8th June 2022) Authors: Stenzl, Arnulf; Szmulewitz, Russell Z.; Petrylak, Daniel; Holzbeierlein, Jeffrey; Villers, Arnauld; Azad, Arun; Alcaraz, Antonio; Alekseev, Boris; Iguchi, Taro; Shore, Neal D.; Gomez‐Veiga, Francisco; Ivanescu, Cristina; Rosbrook, Brad; Ramaswamy, Krishnan; Ganguli, Arijit; Haas, Gabriel P.; Arms... Journal: Prostate Issue: Volume 82:Issue 13(2022) Page Start: 1237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗